Source: Annual Congress 2004 - Functional insights: lung and respiratory muscle
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Vilaró, A. Ramirez-Sarmiento, M. Alvarez, T. Mendoza, N. Sanchez-Cayado, A. Vega, E. Gimeno, N. Sanchez, C. Hernando, I. Diaz, J. Marinez-Llorens, J. Roca, M. Orozco-Levi (Barcelona, Madrid, Oviedo, Las Palmas, Spain). Muscle dysfunction as a systemic marker of risk for exacerbation of COPD patients: the Spanish "IMAGIM study". Eur Respir J 2004; 24: Suppl. 48, 148

Member's Comments

No comment yet.

Related content which might interest you: Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype Source: International Congress 2016 – Monitoring comorbidities Year: 2016 The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013 Sputum characteristics of stable COPD patients after a first admission for an exacerbation. The "phenotype and course of COPD" (PAC-COPD) study Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006 Identification of factors associated with exacerbation risk in severe COPD: Multivariate analysis of the WISDOM study Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Dynapenia in COPD exacerbation: what is its relevance in clinical prognosis? Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy Year: 2017 Metabolic syndrome in patients with COPD and their association with systemic inflammation Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Respiratory symptoms and CRP among participants of the English longitudinal study of ageing (ELSA) – ageing or occult disease? Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005 Sarcopenia in Japanese patients with COPD: prevalence, relationship with COPD severity. Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 How beneficial might be using the Lüscher colour test in the psychological assessment of COPD patients? Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. A comparative syudy Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Eosinophilia as marker of outcome in hospitalised patients with AECOPD Source: Annual Congress 2013 –COPD and infections Year: 2013 Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Phenotyping acute exacerbation of COPD: what more can we do for hospitalised patients? Source: ERJ Open Res, 7 (3) 00362-2021; 10.1183/23120541.00362-2021 Year: 2021 Under reporting acute exacerbation in patient with COPD: incidence and predictors? Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006 Can we identify patients that recover strength following hospitalisation for an acute exacerbation of chronic respiratory disease? Source: International Congress 2015 – Latest insights into pulmonary rehabilitation Year: 2015 Cardiovascular risk assessment in COPD patients with severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 LATE-BREAKING ABSTRACT: Which predictors in COPD patients with the frequent exacerbator phenotype predict the treatment response to maintenance therapy with azithromycin? Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Marfanoid phenotype as a predictor of COPD formation in young patients Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015